<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study investigated the prevalence of Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and its association with P53 expression in a panel of 87 previously untreated nodal non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHLs) from India </plain></SENT>
<SENT sid="1" pm="."><plain>Polymerase chain reaction specific for Epstein Barr nuclear antigen 1 (EBNA1) and EBNA-3C was performed on the lymphnode tissue DNA, while P53 expression was analyzed by immunohistochemistry </plain></SENT>
<SENT sid="2" pm="."><plain>EBV, predominantly type A strain, was detected in 27/87 (31%) nodal lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, 11/46 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 6/17 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 4/6 anaplastic large cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>), 5/11 peripheral T-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e>) and 1/7 lymphoblastic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> was more frequently observed in a specific subset of nodal NHL, suggesting a causative role of <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTCL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>There was no significant association between EBV and P53 expression in our series of NHL patients </plain></SENT>
</text></document>